Richard Gorlick, MD
Enriched profileDivision Head and Department Chair, Pediatrics; H. Grant Taylor, M.D., W.W. Sutow, M.D. and Margaret P. Sullivan, M.D. Distinguished Chair, Pediatrics Patient Care; Director, Pediatric Sarcoma Research Laboratory; Professor, Pediatrics Patient Care · The University of Texas MD Anderson Cancer Center
Richard Gorlick is Division Head and Department Chair, Pediatrics; H. Grant Taylor, M.D., W.W. Sutow, M.D. and Margaret P. Sullivan, M.D. Distinguished Chair, Pediatrics Patient Care; Director, Pediatric Sarcoma Research Laboratory; Professor, Pediatrics Patient Care at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 786 publications with 30,489 citations (h-index 90); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Richard Gorlick, MD, is Division Head and Department Chair, Pediatrics at The University of Texas MD Anderson Cancer Center. The public record shows 786 publications with 30,489 citations (h-index 90), centered on Sarcoma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Sarcoma Diagnosis and Treatment
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 299.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
Sponsor: Children's Oncology Group
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Sponsor: Eleison Pharmaceuticals LLC.
- Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
Sponsor: Children's Oncology Group
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- RECORDATI_RARE_DISEASES_INC.Program year20257 payments
- EMD Serono Research & Development Institute, Inc.Program year20242 payments$11,715openpaymentsdata.cms.gov ↗
- JAZZ PHARMACEUTICALS INC.Program year20221 payment
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
University of Tx Md Anderson Can Ctr
FY2026$202,500U01CA199221 - Project 3: Development of Novel Antibody Drug Conjugates for the Treatment of Osteosarcoma
University of Tx Md Anderson Can Ctr
FY2025$477,912P50CA302482
Congress activity
Updated 27 Aug 2026
140 congress contributions (2005–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 5623: Novel mechanism for eliminating tumor collagens to boost efficacy by attIL12-TIL therapy in PDX sarcoma models
AACR Annual Meeting
AACR2026Co-author - Abstract 7813: Antitumor activity of a B7-H3 antibody-drug conjugate in osteosarcoma patient-derived and metastatic models
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors.
Clinical cancer research
Article2026 - Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models.
Molecular cancer therapeutics
Article2026 - A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.
Clinical cancer research
Clinical Trial2026 - Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas.
Proceedings of the National Academy of Sciences of the United States of America
Article2025 - Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.
Cancer research communications
Article2025
Most-cited works
by citation count (OpenAlex)- 01Osteosarcoma: Current Treatment and a Collaborative Pathway to SuccessArticle1,613 citations2015
- 02Advancing therapy for osteosarcomaArticle895 citations2021
- 03
- 04The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasisArticle720 citations2004
- 05Current and future therapeutic approaches for osteosarcomaArticle719 citations2017
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/richard-gorlick-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/gorlickrichard
Mentions by others
where others cite or feature them- Other
mdanderson.org/newsroom/asco-sharon-giordano-richard-gorlick-honored--2024-special-awards-recipients.h00-159697545.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →federalregister.gov ↗
- Chairman
Bone Tumor Disease Committee (Biology Section–Bone Sarcoma Disease Committee), Children's Oncology Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗ - Member
Medical Advisory Board, Sarcoma Foundation of America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesarcoma.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center